Official Journal of Research Center for Gastroenterology and Liver Diseases
e-ISSN 1735-3408
p-ISSN 1735-143X
Citation data
CrossRef
Works that cite this article, indexed by Crossref.
3 resultsUpdated October 25, 2026
1
A cost-utility analysis of Glecaprevir/Pibrentasvir versus Sofosbuvir/Daclatasvir and Sofosbuvir/Velpatasvir for treatment of hepatitis C in Iran
Cost Effectiveness and Resource Allocation 23(1) (2025)
Mojtaba Jafari; Parisa Mehdizadeh; Khosro Keshavarz; Ehsan Teymourzadeh; Mohammad Ali Abyazi; Seyed Moayed Alavian; Alijanpour Pouria
2
Cost-effectiveness of sofosbuvir- ledipasvir for Hepatitis C treatment: a systematic review
European Journal of Clinical Pharmacology 82(4) (2026)
Nasim Jaberi; Somayeh Afshari; Farhad Khalili; Aziz Rezapour
3
Budget impact analysis of glecaprevir/pibrentasvir treatment for hepatitis C in Iran: a modelling study
BMJ Open 15(9) (2025)
Mojtaba Jafari; Parisa Mehdizadeh; Khosro Keshavarz; Ehsan Teymourzadeh; Mohammad Ali Abyazi; Parsa Gholamreza Shirazi